KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Invested Capital (2016 - 2025)

Historic Invested Capital for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $46.5 billion.

  • Gilead Sciences' Invested Capital rose 1162.85% to $46.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $46.5 billion, marking a year-over-year increase of 1162.85%. This contributed to the annual value of $46.0 billion for FY2024, which is 355.29% down from last year.
  • Per Gilead Sciences' latest filing, its Invested Capital stood at $46.5 billion for Q3 2025, which was up 1162.85% from $44.6 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Invested Capital registered a high of $49.9 billion during Q2 2021, and its lowest value of $41.5 billion during Q2 2024.
  • Moreover, its 5-year median value for Invested Capital was $46.3 billion (2023), whereas its average is $46.1 billion.
  • Per our database at Business Quant, Gilead Sciences' Invested Capital skyrocketed by 15914.39% in 2021 and then crashed by 1182.66% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Invested Capital stood at $47.8 billion in 2021, then fell by 2.77% to $46.4 billion in 2022, then increased by 2.8% to $47.7 billion in 2023, then dropped by 3.55% to $46.0 billion in 2024, then grew by 0.96% to $46.5 billion in 2025.
  • Its Invested Capital was $46.5 billion in Q3 2025, compared to $44.6 billion in Q2 2025 and $44.1 billion in Q1 2025.